Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy

被引：0
|
作者：
Beatriz Alvarado-Castillo
Francisco J. Santa Cruz-Pavlovich
Celia Gonzalez-Castillo
Isaac Alejandro Vidal-Paredes
Leonel Garcia-Benavides
Maria Elena Rosales-Gradilla
Jose Navarro-Partida
机构：
[1] Instituto Mexicano del Seguro Social,
[2] Centro Medico Nacional de Occidente,undefined
[3] Tecnologico de Monterrey,undefined
[4] Escuela de Medicina y Ciencias de la Salud,undefined
[5] Universidad de Guadalajara,undefined
[6] Centro Universitario de Ciencias de la Salud,undefined
来源：
BMC Ophthalmology | / 23卷
关键词：
Efficacy; Eye drops; Interferon alpha 2b; Mitomycin C; Ocular surface squamous neoplasia; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] LONG-TERM SAFETY AND EFFICACY OF PROPAFENONE - A 2 YEAR EXPERIENCE
    HA, D
    BAKER, BJ
    MURPHY, ML
    DESOYZA, N
    FRANCIOSA, JA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (02) : 189 - 189
  • [32] EFFICACY, SAFETY, AND TOLERANCE OF LOW-DOSE, LONG-TERM INTERFERON-ALPHA(2B) AND ZIDOVUDINE IN EARLY-STAGE AIDS-ASSOCIATED KAPOSIS-SARCOMA
    MAUSS, S
    JABLONOWSKI, H
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 (02): : 157 - 162
  • [33] Retrospective Comparative Study of Topical Interferon α2b Versus Mitomycin C for Primary Ocular Surface Squamous Neoplasia
    Kusumesh, Rakhi
    Ambastha, Anita
    Kumar, Shishir
    Sinha, Bibhuti Prasan
    Imam, Nazia
    CORNEA, 2017, 36 (03) : 327 - 331
  • [34] Efficacy and safety of interferon α-2b spray for herpangina in children: A randomized, controlled trial
    Ye, Ying-Zi
    Dou, Ya-Lan
    Hao, Jian-Hua
    Zhou, Li
    Lin, Ai-Wei
    Wang, Shao-Ning
    Deng, Ji-Kui
    Lei, Min
    Luo, Ru-Ping
    Liao, Yi-Nan
    Chen, Yan
    Long, Yuan-Yuan
    Chen, Bi-Quan
    Yang, Zhi
    Gan, Lu
    Nong, Guang-Min
    Yan, Wei-Li
    Yu, Hui
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 107 : 62 - 68
  • [35] Pegylated interferon-α2b:: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data
    Glue, P
    Fang, JWS
    Rouzier-Panis, R
    Raffanel, C
    Sabo, R
    Gupta, SK
    Salfi, M
    Jacobs, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (05) : 556 - 567
  • [36] LONG-TERM SAFETY AND EFFICACY OF MIRAVIRSEN IN CHRONIC HEPATITIS C PATIENTS
    van der Ree, M. H.
    van der Meer, A. J.
    de Bruijne, J.
    van Vliet, A.
    Welzel, T. M.
    Lawitz, E. J.
    Rodrigues-Torres, M.
    Kupcova, V.
    Wiercinska-Drapalo, A.
    Hodges, M. R.
    Janssen, H. L. A.
    Reesink, H. W.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S443 - S443
  • [37] Efficacy and safety of pegylated interferon alpha-2b and ribavirin in chronic hepatitis C in children
    Kups-Rzepecka, Joanna
    Golabek, Violetta
    Kicinski, Przemyslaw
    Wozniakowska-Gesicka, Teresa
    PRZEGLAD GASTROENTEROLOGICZNY, 2010, 5 (06): : 341 - 348
  • [38] Study of efficacy and safety of reconstituted, recombinant human interferon alpha 2b eyedrops without refrigeration as a therapy for immunoreduction and/or treatment of ocular surface squamous neoplasia
    Kabra, Namrata S.
    Patil, Vaibhav S.
    Dhanuka, Dolly G.
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (12) : 3776 - 3777
  • [39] Long term treatment of myeloproliferative disease with interferon-α-2b -: Feasibility and efficacy
    Gilbert, HS
    CANCER, 1998, 83 (06) : 1205 - 1213
  • [40] Efficacy and safety of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patients
    Landau, AO
    Batisse, DP
    van Huen, PD
    Piketty, C
    Bloch, F
    Pialoux, G
    Petite, JP
    Weiss, L
    Kazatchkine, M
    HEPATOLOGY, 1999, 30 (04) : 367A - 367A
12345